|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||156.55 - 158.69|
|52 Week Range||132.40 - 159.41|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.20%|
Large-cap and growth stocks continue to beat small-caps and value, even though everyone thought the tide would turn this year.
A potential problem for value investors that favor index funds in the months ahead: Value indexes are loaded to the gills with competing holdings that are likely to offset each other.
With covered calls, you are selling the right for someone else to buy a security from you at a given price on or before a certain date. If you sell covered calls on a stock and that contract gets triggered because the price has gone above that contract’s strike price, you will be forced to sell the stock. The SPDR S&P 500 ETF (NYSEARCA:SPY) is that core ETF that many people own, one which holds all the stocks in the S&P 500.
Insys’s (INSY) net revenues decreased from $57.7 million in 3Q16 to $30.7 million in 3Q17, which was attributable to a decrease in Subsys sales. As a result, the gross profit of the company decreased to $23.1 million in 3Q17 as compared with $53 million for 3Q16. The general and administrative expenses of the company decreased to $15.7 million in 3Q17 as compared with $17.7 million for 3Q16.
Tuscon-based Accelerate Diagnostics (AXDX) is a diagnostics company focused on developing solutions and tools to provide rapid diagnostic results. While results from traditional culture-based tests usually take two to three days, Accelerate’s technology platform is built to deliver substantially faster and more accurate testing of infectious pathogens. The platform is intended to rapidly diagnose infectious pathogens.
Credit Suisse’s Jonathan Golub called out his fellow Wall Street strategists this week for playing it too conservative in crunching the earnings boost from corporate tax cuts.
The agreement granted Ignyta exclusive global rights to develop and commercialize entrectinib. Under the license, Ignyta’s development rights are exclusive for entrectinib for the term of the agreement. The license also grants exclusive rights to Ignyta for a term of five years with respect to any product candidate that NMS might develop that has activity against the target proteins of entrectinib.
Despite the quadrupling of the stock market from the 2009 bottom, money may just be in the early stages of moving out of bonds and cash, and back into stocks.
The Conference Board LCI (Leading Credit Index), a constituent in the LEI (Leading Economic Index), is published every month and tracks credit conditions in the US economy by following changes in…
As we kick off this new year please remember that markets don’t trade in a linear fashion even though 2017, as far as U.S. equities are concerned, in many ways displayed a record amount of linearity with 12 consecutive months of gains for the S&P 500 as represented by the SPDR S&P 500 ETF Trust (NYSEARCA:SPY). Yes keep the broader stock market trends of past years in mind for perspective, but do not let this derail you from respecting price action.
Monero is becoming the cryptocurrency of choice, edging out bitcoin, according to Bloomberg? Is this good or bad for bitcoin? Yahoo Finance's Seana Smith discusses the latest market action with Jared Blikre live from the floor of the New York Stock Exchange.